• SEC charges ex-Sangamo exec with insider trading fiercebiotech
    August 27, 2018
    The SEC has charged former Sangamo BioSciences executive Winson Tang with insider trading. Tang is accused of telling a friend about a 2014 agreement between Sangamo and Biogen before the news became public.
PharmaSources Customer Service